We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Seadrill
SDRL
$2.81B
| $77.3K | 0.01% |
2,044
+128
| +7% | +$5.96K |
|
1077
Fluor
FLR
$7.29B
| $76.8K | 0.01% |
1,466
+113
| +8% | +$5.53K |
|
|
FISV
1078
Fiserv Inc
FISV
$27.2B
| $76.7K | 0.01% |
1,563
-867
| -36% | -$48.5K |
|
1079
Rogers Corp
ROG
$2.33B
| $76.6K | 0.01% |
468
-60
| -11% | -$8.25K |
|
1080
Ooma
OOMA
$550M
| $76.6K | 0.01% |
3,985
| – | – |
|
1081
Comstock Resources
CRK
$3.97B
| $76.5K | 0.01% |
5,127
+4,626
| +923% | +$70.7K |
|
1082
Schwab US Large- Cap ETF
SCHX
$70.9B
| $76.3K | 0.01% |
2,593
+1,313
| +103% | +$37.5K |
|
1083
Avient
AVNT
$3.45B
| $76K | 0.01% |
2,057
+221
| +12% | +$8K |
|
1084
Alkermes
ALKS
$8.82B
| $75.7K | 0.01% |
1,445
+366
| +34% | +$14.3K |
|
1085
SiriusXM
SIRI
$10B
| $75.7K | 0.01% |
2,562
+560
| +28% | +$15K |
|
1086
Q2 Holdings
QTWO
$3.42B
| $75.5K | 0.01% |
1,570
+489
| +45% | +$23.2K |
|
1087
Asbury Automotive
ABG
$4.19B
| $75.4K | 0.01% |
375
+264
| +238% | +$52K |
|
1088
Veralto
VLTO
$22.6B
| $75.2K | 0.01% |
848
-12
| -1% | -$1.04K |
|
1089
Armstrong World Industries
AWI
$6.86B
| $75.1K | 0.01% |
468
-183
| -28% | -$29.9K |
|
1090
Align Technology
ALGN
$12B
| $75.1K | 0.01% |
445
-69
| -13% | -$12K |
|
1091
Xylem
XYL
$28.5B
| $74.9K | 0.01% |
634
-1,342
| -68% | -$155K |
|
1092
Idacorp
IDA
$8.23B
| $74.6K | 0.01% |
493
| – | – |
|
1093
John B. Sanfilippo & Son
JBSS
$949M
| $74.6K | 0.01% |
867
+86
| +11% | +$6.8K |
|
|
SOLS
1094
Solstice Advanced Materials
SOLS
$9.62B
| $74.4K | 0.01% |
840
-1
| -0.1% | -$82 |
|
1095
Qualys
QLYS
$4.84B
| $74.4K | 0.01% |
541
+266
| +97% | +$26.2K |
|
1096
Rubrik
RBRK
$15.1B
| $74.3K | 0.01% |
926
+327
| +55% | +$20.6K |
|
1097
Agios Pharmaceuticals
AGIO
$2.16B
| $74.3K | 0.01% |
2,001
+1,583
| +379% | +$48K |
|
1098
Weave Communications
WEAV
$491M
| $74.2K | 0.01% |
12,388
+9,029
| +269% | +$49.2K |
|
1099
Advanced Drainage Systems
WMS
$10.9B
| $74.1K | 0.01% |
472
-381
| -45% | -$54.4K |
|
1100
Strategy Inc
MSTR
$33.5B
| $74K | 0.01% |
851
-58
| -6% | -$8.42K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.